JP2024534162A5 - - Google Patents
Info
- Publication number
- JP2024534162A5 JP2024534162A5 JP2024513053A JP2024513053A JP2024534162A5 JP 2024534162 A5 JP2024534162 A5 JP 2024534162A5 JP 2024513053 A JP2024513053 A JP 2024513053A JP 2024513053 A JP2024513053 A JP 2024513053A JP 2024534162 A5 JP2024534162 A5 JP 2024534162A5
- Authority
- JP
- Japan
- Prior art keywords
- amino
- trifluoromethyl
- methylpiperidine
- phenol
- triazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163237049P | 2021-08-25 | 2021-08-25 | |
| US63/237,049 | 2021-08-25 | ||
| US202263311463P | 2022-02-18 | 2022-02-18 | |
| US63/311,463 | 2022-02-18 | ||
| PCT/US2022/075421 WO2023028534A1 (en) | 2021-08-25 | 2022-08-24 | Inhibitors of nlrp3 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534162A JP2024534162A (ja) | 2024-09-18 |
| JP2024534162A5 true JP2024534162A5 (OSRAM) | 2025-09-02 |
Family
ID=83438923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513053A Pending JP2024534162A (ja) | 2021-08-25 | 2022-08-24 | Ｎｌｒｐ３の阻害剤 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20240262806A1 (OSRAM) |
| EP (1) | EP4392414A1 (OSRAM) |
| JP (1) | JP2024534162A (OSRAM) |
| KR (1) | KR20240069714A (OSRAM) |
| AU (1) | AU2022334474A1 (OSRAM) |
| CA (1) | CA3229539A1 (OSRAM) |
| CL (1) | CL2024000552A1 (OSRAM) |
| CO (1) | CO2024001922A2 (OSRAM) |
| CR (1) | CR20240093A (OSRAM) |
| EC (1) | ECSP24014832A (OSRAM) |
| IL (1) | IL310992A (OSRAM) |
| MX (1) | MX2024002342A (OSRAM) |
| PE (1) | PE20241727A1 (OSRAM) |
| WO (1) | WO2023028534A1 (OSRAM) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11618751B1 (en) | 2022-03-25 | 2023-04-04 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives |
| US11319319B1 (en) | 2021-04-07 | 2022-05-03 | Ventus Therapeutics U.S., Inc. | Compounds for inhibiting NLRP3 and uses thereof |
| TW202319055A (zh) * | 2021-07-21 | 2023-05-16 | 日商安斯泰來製藥股份有限公司 | 縮環噠嗪（ｐｙｒｉｄａｚｉｎｅ）化合物 |
| CN118302417A (zh) * | 2021-08-25 | 2024-07-05 | Ptc医疗公司 | Nlrp3抑制剂 |
| US20240391881A1 (en) * | 2021-09-30 | 2024-11-28 | Origiant Pharmaceutical Co., Ltd. | Pharmaceutical use and preparation method for substituted heteroaryl phthalazine derivative |
| EP4433480A1 (en) | 2021-11-17 | 2024-09-25 | F. Hoffmann-La Roche AG | Heterocyclic nlrp3 inhibitors |
| WO2023178099A1 (en) * | 2022-03-15 | 2023-09-21 | Zomagen Biosciences Ltd | Nlrp3 modulators |
| IL315842A (en) * | 2022-03-25 | 2024-11-01 | Ventus Therapeutics U S Inc | Pyrido-[4,3-D]pyridazine amine derivatives are useful as NLRP3 derivatives |
| JP2025511199A (ja) * | 2022-03-31 | 2025-04-15 | ハンチョウ ハイライトゥル ファーマシューティカル カンパニー リミテッド | Ｎｌｒｐ３インフラマソーム阻害剤 |
| US20260015357A1 (en) * | 2022-07-01 | 2026-01-15 | Neumora Therapeutics, Inc. | Modulators of nlrp3 inflammasome and related products and methods |
| EP4554945A1 (en) * | 2022-07-14 | 2025-05-21 | AC Immune SA | Pyrrolotriazine and imidazotriazine derivatives as modulators of the nlrp3 inflammasome pathway |
| KR20250069659A (ko) * | 2022-09-23 | 2025-05-19 | 머크 샤프 앤드 돔 엘엘씨 | Nod-유사 수용체 단백질 3의 억제제로서 유용한 프탈라진 유도체 |
| US12331048B2 (en) | 2022-10-31 | 2025-06-17 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors |
| CN121045190A (zh) * | 2022-11-04 | 2025-12-02 | 药捷安康(南京)科技股份有限公司 | Nlrp3炎症小体抑制剂及其应用 |
| EP4644392A1 (en) * | 2022-12-27 | 2025-11-05 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Pyridazine fused aryl ring compound and use thereof |
| AU2023417544A1 (en) * | 2022-12-28 | 2025-07-17 | Changchun Genescience Pharmaceutical Co., Ltd. | Pyridazine nlrp3 inhibitor compound, pharmaceutical composition, and preparation method therefor and use thereof |
| EP4658644A1 (en) * | 2023-01-31 | 2025-12-10 | Janssen Pharmaceutica NV | 2-(pyridazin-3-yl)-5-(trifluoromethyl)phenols as nlrp3 inhibitors |
| EP4658654A1 (en) * | 2023-01-31 | 2025-12-10 | Janssen Pharmaceutica NV | Pyrrolo[1,2-d][1,2,4]triazines and pyrazolo[1,5-d] [1,2,4]triazines as nlrp3 inhibitors |
| CN121219275A (zh) * | 2023-03-14 | 2025-12-26 | 赛诺菲 | 哒嗪化合物、其制备及其治疗用途 |
| CN120659791A (zh) * | 2023-04-17 | 2025-09-16 | 上海拓界生物医药科技有限公司 | 稠合哒嗪类衍生物及其用途 |
| EP4719599A1 (en) | 2023-06-02 | 2026-04-08 | Merck Sharp & Dohme LLC | 5,6 unsaturated bicyclic heterocyles useful as inhibitors of nod-like receptor protein 3 |
| CN121909186A (zh) * | 2023-06-27 | 2026-04-21 | 唯久生物(美国)有限公司 | 作为nlrp3活性抑制剂的取代哒嗪化合物及其治疗用途 |
| WO2025133307A1 (en) * | 2023-12-22 | 2025-06-26 | Ac Immune Sa | Heterocyclic modulators of the nlrp3 inflammasome pathway |
| WO2025146160A1 (zh) * | 2024-01-05 | 2025-07-10 | 北京普祺医药科技股份有限公司 | 杂环化合物及其药物组合物 |
| WO2025153532A1 (en) | 2024-01-16 | 2025-07-24 | NodThera Limited | Nlrp3 inhibitors and glp-1 agonists combination therapies |
| WO2025153625A1 (en) * | 2024-01-17 | 2025-07-24 | Ac Immune Sa | Imidazo[1,2-d][1,2,4]triazine derivatives for use as inhibitors of the nlrp3 inflammasome pathway |
| WO2025153624A1 (en) * | 2024-01-17 | 2025-07-24 | Ac Immune Sa | Imidazo[1,2-d][1,2,4]triazine derivatives for use as inhibitors of the nlrp3 inflammasome pathway |
| WO2026002229A1 (zh) * | 2024-06-28 | 2026-01-02 | 长春金赛药业有限责任公司 | 一种nlrp3抑制剂化合物及其制备方法和应用 |
| WO2026047040A1 (en) * | 2024-08-28 | 2026-03-05 | Sanofi | Pyridazine compounds, their preparation, and their therapeutic uses |
| WO2026057747A1 (en) | 2024-09-11 | 2026-03-19 | Ac Immune Sa | Therapeutic use of nlrp3 inflammasome pathway inhibitor compounds |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9919957D0 (en) * | 1999-08-23 | 1999-10-27 | Merck Sharp & Dohme | Therapeutic agents |
| WO2006075638A1 (ja) | 2005-01-14 | 2006-07-20 | Dainippon Sumitomo Pharma Co., Ltd. | 新規ヘテロアリール誘導体 |
| US8222251B2 (en) * | 2007-09-07 | 2012-07-17 | Amgen Inc. | Pyridopyridazine compounds, compositions and methods of use |
| WO2018080216A1 (en) * | 2016-10-28 | 2018-05-03 | Daewoong Pharmaceutical Co., Ltd. | Phenyl phthalazine derivative, method for the preparation thereof, and pharmaceutical composition comprising the same |
| CN114245794B (zh) | 2019-05-13 | 2024-09-13 | Ptc医疗公司 | 用于治疗亨廷顿氏病的化合物 |
| UY38687A (es) * | 2019-05-17 | 2023-05-15 | Novartis Ag | Inhibidores del inflamasoma nlrp3, composiciones, combinaciones de los mismos y métodos para su uso |
| WO2020239076A1 (zh) | 2019-05-29 | 2020-12-03 | 南京明德新药研发有限公司 | 作为甲状腺素受体-β激动剂的哒嗪酮类衍生物及其应用 |
| US20240391895A1 (en) * | 2020-12-25 | 2024-11-28 | Tuojie Biotech (Shanghai) Co., Ltd. | Pyridazine-containing compound and medicinal use thereof |
| US11319319B1 (en) * | 2021-04-07 | 2022-05-03 | Ventus Therapeutics U.S., Inc. | Compounds for inhibiting NLRP3 and uses thereof |
| US20240327413A1 (en) | 2021-06-29 | 2024-10-03 | Zomagen Biosciences Ltd | Nlrp3 modulators |
| HRP20251513T1 (hr) | 2021-07-02 | 2026-01-02 | Astrazeneca Ab | Inhibitori inflamasoma nlrp3 |
| TW202319055A (zh) | 2021-07-21 | 2023-05-16 | 日商安斯泰來製藥股份有限公司 | 縮環噠嗪（ｐｙｒｉｄａｚｉｎｅ）化合物 |
-
2022
- 2022-08-24 PE PE2024000299A patent/PE20241727A1/es unknown
- 2022-08-24 US US18/256,099 patent/US20240262806A1/en active Pending
- 2022-08-24 JP JP2024513053A patent/JP2024534162A/ja active Pending
- 2022-08-24 KR KR1020247005965A patent/KR20240069714A/ko active Pending
- 2022-08-24 WO PCT/US2022/075421 patent/WO2023028534A1/en not_active Ceased
- 2022-08-24 IL IL310992A patent/IL310992A/en unknown
- 2022-08-24 EP EP22777142.5A patent/EP4392414A1/en active Pending
- 2022-08-24 CA CA3229539A patent/CA3229539A1/en active Pending
- 2022-08-24 CR CR20240093A patent/CR20240093A/es unknown
- 2022-08-24 MX MX2024002342A patent/MX2024002342A/es unknown
- 2022-08-24 AU AU2022334474A patent/AU2022334474A1/en active Pending
-
2024
- 2024-02-22 CO CONC2024/0001922A patent/CO2024001922A2/es unknown
- 2024-02-22 CL CL2024000552A patent/CL2024000552A1/es unknown
- 2024-02-23 EC ECSENADI202414832A patent/ECSP24014832A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL310992A (en) | NLRP3 inhibitors | |
| CN109071498B (zh) | 激酶抑制剂及其制备方法和用途 | |
| JP7010935B2 (ja) | Ｕｓｐ３０の阻害剤としての活性を有するシアノ置換ヘテロ環 | |
| JP6495886B2 (ja) | Ｂｔｋ阻害剤としての複素環式芳香族化合物 | |
| RU2610262C2 (ru) | ХИНОЛИНКАРБОКСАМИДНЫЕ И ХИНОЛИНКАРБОНИТРИЛЬНЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ mGLuR2-НЕГАТИВНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ, КОМПОЗИЦИИ И ИХ ПРИМЕНЕНИЕ | |
| ES2942211T3 (es) | Inhibidores de la O-glucoproteína-2-acetamido-2-desoxi-3-D-glucopiranosidasa | |
| JP2021505553A (ja) | 新規化合物及び疾患の治療のためのその医薬組成物 | |
| JP2024519496A (ja) | ブルトンのチロシンキナーゼの分解を標的化するための化合物 | |
| MX2009001913A (es) | Compuestos de pirimidona como inhibidores de gsk-3. | |
| CA2979024C (en) | Fused bicyclic heteroaryl derivatives having activity as phd inhibitors | |
| JP2021527106A (ja) | 新規化合物及び疾患の治療のためのその医薬組成物 | |
| US12049462B2 (en) | Tri-substituted aryl and heteroaryl derivatives as modulators of PI3-kinase and autophagy pathways | |
| CN119212699A (zh) | Nlrp3抑制剂 | |
| WO2016064957A1 (en) | Bicyclic heteroaryl amine compounds as pi3k inhibitors | |
| JP2015526411A (ja) | 窒素複素環誘導体及びその医薬品への応用 | |
| JP7854219B2 (ja) | ペプチジルニトリル化合物及びその使用 | |
| TW201821417A (zh) | 苯氧基三唑 | |
| ES2976515T3 (es) | Compuestos y composiciones para tratar afecciones asociadas con la actividad del receptor APJ | |
| US20230295166A1 (en) | Atr inhibitors and uses thereof | |
| JP6515175B2 (ja) | 芳香族ヘテロ環誘導体及びその医薬的適用 | |
| CN121925409A (zh) | 补体因子b抑制剂及其用途 | |
| EP3704097A1 (en) | Bicyclic sulfones and sulfoxides and methods of use thereof | |
| WO2022011274A1 (en) | Substituted 1,6-naphthyridine inhibitors of cdk5 | |
| JP2025506667A (ja) | エモパミル結合タンパク質阻害剤及びその使用 | |
| AU2023357827A1 (en) | Cyclopentane compound |